Prevalence of hepatitis A, B and C serological markers in children from western Mexico

Annals of Hepatology

Volumn 11, Issue 2, 2012, Pages 194-201

  Escobedo Meléndez, Griselda ^a   Fierro, Nora A ^a   Roman, Sonia ^a   Maldonado González, Monserrat ^a   Zepeda Carrillo, Eloy ^a   Panduro, Arturo ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Hepatitis A virus; Hepatitis B virus; Hepatitis C virus; Mexican children

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M;

ADOLESCENT; AGE; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEXICO; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SCREENING TEST; SEROLOGY; VIRUS HEPATITIS;

EID: 84856906571     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31024-5     Document Type: Article

References (36)

1. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int 2010; 30(1): 5-18.
2. Dhawan A. Etiology and prognosis of acute liver failure in children. Liver Transpl 2008; 14(S2): S80-S84.
3. Broderick AL, Jonas MM. Hepatitis B in Children. Semin Liver Dis 2003; 23(1): 59-68.
4. Zein NN. Hepatitis C in children: recent advances. Curr Opin Pediatr 2007; 19: 570-4.
5. Jackobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005-22.
6. Kelly D. Viral hepatitis B and C in children. J R Soc Med 2006; 99: 353-7.
7. Indolfi G, Resti M. Perinatal transmission of hepatitis C virus infection. J Med Virol 2009; 81(5): 836-43.
8. Panduro A, Escobedo-Melendez G, Fierro NA, Ruiz-Madrigal B, Carrillo E, Roman S. Epidemiología de las hepatitis virales en México. Sal Pub Mex 2011; 53(S1): S37-S45.
9. Roman S, Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez Van Dyck M, Martínez-López E, et al. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int 2009; 3: 343-55.
10. Panduro A, Roman S, Khan A, Tanaka Y, Kurbanov F, Martinez-Lopez E, Campollo O, et al. Molecular epidemiology of hepatitis C virus genotypes in west Mexico. Virus Res 2010; 151: 19-25.
11. Chiquete E, Panduro A. Low prevalence of anti hepatitis C virus antibodies in Mexico: a systematic review. Intervirol 2007; 50: 1-8.
12. Valdespino JL, Ruiz-Gomez J, Olaiz-Fernandez G, Arias-Toledo E, Conde-Gonzalez C, Palma O, Sepúlveda J. Seroepidemiología de la hepatitis A en México. Sensor de inequidad social e indicador de políticas de vacunación. Sal Pub Mex 2007; 49(S-3): 377-85.
13. Kumate J, Alvizouri AM, Isibasi A. Encuesta serológica de hepatitis A en niños de México. Bol of Sanit Panam 1982; 92: 494-9.
14. Bustamante-Calvillo ME, Velázquez-Castillo FR, Padilla-Noriega L, Álvarez y Muñoz MT, Moreno-Altamirano L, Martínez-García MC. Seroepidemiology of hepatitis A virus infection in communities of the southern border of the State of Chiapas. Bol Med Hosp Infant Mex 1986; 43: 735-41.
15. Bustamante-Calvillo ME, Corea BM, Alvarez, Muñoz MT, Ruiz-Gomez J, Muñoz HO. Etiología de la hepatitis en la ciudad de México. Bol Med Hosp Infant Mex 1986; 43: 5-10.
16. Tapia Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, Potin M, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Hyg 1999; 61(5): 825-29.
17. Weinberg M, Hopkins J, Farrington L, Gresham L, Ginsberg M, Bell BP. Hepatitis A in Hispanic children who live along the United States-Mexico border: The role of international travel and food-borne exposures. Pediatrics 2004; 114(1): 68-73.
18. García-Juárez I, Solórzano F, Álvarez-y-Muñoz MT, Vázquez-Rosales JG. ¿Existe transición en el patrón endemic de la hepatitis A en población infantil Mexicana? Rev Inv Clin 2008; 60: 292-6.
19. Silveira TH, da Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, et al. Hepatitis B seroprevalence in Latin America. Pan Am J Public Health 1999; 6(6): 378-83.
20. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000; 18: S17-S19.
21. Cisneros-Castolo M, Hernandez-Ruiz L, Ibarra-Robles IE, Fernandez-Garate IH, Escobedo-De la Peña J. Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. Am J Trop Med Hyg 2001; 65(6): 759-63.
22. Hernández-Arriaga JL, Ramírez-Crespo A, Anda-Gómez M. Marcadores serológicos de hepatitis B en la etapa neonatal. Bol Med Hosp Infant Mex 2000; 57(12): 682-4.
23. Cervantes BR, Ramírez MJ, Zarate MF, Mata RN, Munguía VP, Mason CT, Ferreiro MA, et al. Marcadores serológicos para el virus de hepatitis B en un grupo de niños mexicanos. Act Ped Mex 2002; 23(6): 352-4.
24. Baptista-González HA, Kourchenko-Raab H, Rosenfeld-Mann F, Rizo-Almenara S, Peñuela-Olaya MA. Estudio de infecciones virales en el lactante menor transfundido en la etapa neonatal. Bol Med Hosp Infant Mex 1998; 55(7): 386-92.
25. Squires RH, Shneider BL, Bucuvalas J. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148(5): 652-8.
26. Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 2006; 19(1): 63-79.
27. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. AASLD practice guideline update. Hepatol 2009; 50(3): 1-36.
28. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C: An update. Hepatol 2009; 49(4): 1335-74.
29. Sanchez LV, Tanaka Y, Maldonado M, Mizokami M, Panduro A. Difference of hepatitis B virus genotype distribution in two groups of Mexican patients with different risk factors. Intervirol 2007; 50: 9-15.
30. Stanton BF. Growth, development an behavior. In: Kliegman RM, Behrman RE, Jenson HB (eds.). Nelson textbook of Pediatrics. 18th. Ed. Saunders Elsevier; 2007, p. 33-91.
31. Committee on Infectious Diseases, American Academy of Pediatrics. Hepatitis A vaccine recommendations. Pediatrics 2007; 120: 189-99.
32. Hollinger FB, Bell B, Levy-Bruhl D, Shouval D, Wiersma S, Van Damme P. Hepatitis A and B vaccination and public health. J Viral Hepatitis 2007; 14(S1): 1-15.
33. Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, Panduro A. Occult Hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol 2010; 82(9): 1527-36.
34. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, et al. Statements from the Taormina experts meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-57.
35. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review an analysis. Epidemiol Infect 2004; 132: 1005-22.
36. Secretaría de Salud de México. Cartilla Nacional de Vacunación. Available from: http://salud.edomex.gob.mx/sa-lud/cartillas.html.